Conventional Hip Screws Market - Global Forecast 2025-2032

The conventional hip screws market is experiencing dynamic transformation as healthcare providers and procurement teams prioritize advanced technology, sustainability, and operational efficiency in orthopedic care. This evolution reflects the growing demand for consistently positive musculoskeletal outcomes achieved through innovation and value-based strategies.

Market Snapshot: Conventional Hip Screws Market

The conventional hip screws market progressed from USD 421.32 million in 2024 to USD 446.60 million in 2025, with projections indicating an increase to USD 664.95 million by 2032, representing a CAGR of 5.86%. Expansion is driven by rising hip fracture incidence, along with innovation in surgical device design and a clear focus on minimizing hospitalization time. The sector supports ongoing healthcare objectives centered on reproducible, cost-effective solutions. Healthcare facilities are moving toward next-generation hardware, signaling new priorities in clinical care and procurement strategies.

Scope & Segmentation

This report delivers an actionable review of the conventional hip screws market, with segmentation and insights supporting senior operational and clinical decisions:

• Application: Encompasses hardware for reconstructive and trauma procedures, addressing the diverse range of patient cases needing flexible, clinically-proven solutions.
• End User: Evaluates usage in ambulatory surgery centers, hospitals, orthopedic clinics, and trauma centers, allowing for the selection of product offerings matched to distinct patient throughput and care models.
• Distribution Channel: Explores both direct sales to providers and integration with regional and global distributors, supporting robust supply chain management.
• Material: Considers the advantages of bioabsorbable options, stainless steel, and titanium, enabling device choices aligned with institutional protocols and individual patient needs.
• Surgical Approach: Reviews device compatibility with minimally invasive and open procedures, allowing providers to adapt hardware selection to advances in surgical technique and evolving care standards.
• Product Type: Reviews cannulated hip screws (6.5 mm, 7.3 mm, 8.0 mm), dynamic hip screw systems (single and double barrel types), as well as locking and non-cannulated, nonlocking screws, supporting optimal clinical matching across cases.
• Regional Coverage: Includes coverage across Americas, Europe, Middle East, Africa, and Asia-Pacific markets, shedding light on distinct healthcare policies, infrastructures, and growth drivers pertinent to each region.
• Leading Companies: Details the role of major market participants such as Johnson & Johnson Services, Stryker, Zimmer Biomet, Smith & Nephew, Medtronic, Wright Medical, B. Braun, Arthrex, CONMED, and Acumed. Each company influences product innovation and competitive dynamics through specialized strategies and investments.

Key Takeaways for Senior Decision-Makers

• Adoption of digital platforms and integrated planning tools is facilitating improved surgical precision. These innovations contribute to shorter patient recovery times and more efficient operating room management.
• Emerging regulatory consistency and the movement toward value-based procurement streamline the introduction of advanced orthopedic devices, enhancing purchasing options grounded in clinical evidence.
• Segmentation by end user and procedural approach supports tailored product strategies, positioning suppliers to align closely with the requirements of specific healthcare environments.
• Procurement teams are emphasizing solutions that feature advanced digital integration, sustainability considerations, and paired service offerings to optimize care delivery and organizational value.
• Collaboration with research partners and clinical experts, alongside the adoption of environmentally responsible manufacturing, enables differentiation and alignment with institutional sustainability goals.

Tariff Impact on Supply Chain and Manufacturing

Recent U.S. tariff policy developments are prompting companies to rethink hip screw sourcing and manufacturing strategies. Organizations are expanding supplier networks, relocating production operations, and updating inventory practices to remain agile in an evolving regulatory environment. Domestic manufacturers are improving risk management and revisiting supplier contracts to secure pricing advantages, contributing to a more resilient supply chain framework.

Methodology & Data Sources

The assessment combines primary interviews with clinical leaders and industry experts, regulatory and patent reviews, and a thorough evaluation of peer-reviewed literature. Cross-referencing of these data sources ensures reliable findings, while frameworks such as SWOT and Porter’s Five Forces underpin the resulting practical insights.

Why This Report Matters

• Clarifies the most significant regulatory and reimbursement challenges so executive teams can navigate opportunity, risk, and investment with greater confidence in the conventional hip screws market.
• Equips organizations to pursue targeted portfolio development, drawing on granular segmentation for tailored clinical and regional growth strategies.
• Uncovers evolving technology and partnership opportunities that inform sustainable market positioning and ongoing organizational competitiveness.

Conclusion

The conventional hip screws market continues to adapt, shaped by material advancements, evolving operating models, and shifting clinical requirements. Strategic agility and innovation remain vital for organizations seeking sustainable long-term growth in orthopedic solutions.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.